Skip to main content
Tech.euFundingExplorerBeta

AVEA

The longevity supplement start-up with the aim to improve health-span

AVEA has raised €4.7M across 3 funding rounds from 4 investors, most recently a round in Oct 2026. Based in Zug, Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€4.7M
€4,720,638
Funding rounds
3
Investors
4
distinct backers
Active since
2022-06
latest 2026-10

Funding by year

EUR raised per year · 2026 YTD
AVEA — funding by year — interactive chart.
Data table
AVEA — funding by year
2022€2.4M
2023€2.3M
2026€0

Signals

High confidence
Raise-next likelihood10
base rate 30% for Other
  • ▼ Raised very recently
  • ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
  • ▲ Recently backed by strong-exit-track investors

Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2026-10-23Other—Lara Gut-BehramiView deal →
2023-07-04Seed€2.3MMaximonView deal →
2022-06-01Other€2.4MLongevity Co-Investment Fund,Maximon,The Longevity Company BuilderView deal →

Similar companies

same sector or country

Global coverage: FundingData